Pharma And Agritech Groups Push Against Biodiversity Levy At UN Summit
The summit will discuss a slate of essential actions needed to stem biodiversity loss, such as protecting 30 per cent of the planet’s land and water by 2030. In 2022, the world. Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from products made using genetic data. Pharma giants may be working against public opinion. An online poll conducted in the uk last week surveyed 1200 people for their take on this issue.
The world's largest nature protection conference opened in colombia monday. Pharma and agritech groups push against biodiversity levy at un summit. One contentious proposal seeks to impose 1% levy on returns from products made using genetic. The un biodiversity summit known as cop16 officially opened in colombia on monday, and hopes are high that negotiating countries can agree on a path forward to.